Last updated: September 2, 2023
Sponsor: Katja Haemmerli Keller
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vaginal Cancer
Pelvic Cancer
Neoplasms
Treatment
Mind-Body Online Therapy
Clinical Study ID
NCT05313724
2022-00174
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- At least 18 years old
- Oncologic disease: first diagnosed; within the first 12 weeks of diagnosis, first-linetreatment (either systemic treatment - including chemotherapy, hormonal therapy ortargeted therapy - or radiotherapy), Notes: (1) Patients treated for first recurrenceof a tumor previously treated with curative intent are also eligible. (2)Psychological distress is taken into account by stratification according to the stressthermometer. In research, this procedure corresponds to the current state-of-the-art.Individual subgroups (e.g. cancer stages) can then be studied post-hoc.
- Sufficient computer skills and internet access
- Availability of an emergency address
- Written informed consent by signing the informed consent form
Exclusion
Exclusion Criteria:
- Patient unable to provide written informed consent by signing informed consent form
- Insufficient knowledge of German
- Moderate to severe depressive symptomatology (BDI > 18; HAM-D17 ≥ 17) during T1 survey
- Suicidality (BDI suicidality item > 1; HAM-D17 suicidality item ≥ 2) in the context ofthe T1 survey
- Diagnosis of psychotic, bipolar, or other serious mental or somatic disorder requiringimmediate treatment
- Male breast cancer patients
Study Design
Total Participants: 120
Treatment Group(s): 1
Primary Treatment: Mind-Body Online Therapy
Phase:
Study Start date:
July 01, 2022
Estimated Completion Date:
August 31, 2024
Connect with a study center
Clinic for Psychosomatic Medicine and Consultation-Liaison Psychiatry
St.Gallen, 9007
SwitzerlandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.